NASDAQ:MGTX - MeiraGTx Stock Price, Forecast & News

MeiraGTx trades on the NASDAQ under the ticker symbol "MGTX."

MeiraGTx Holdings PLC (NASDAQ:MGTX) issued its earnings results on Thursday, November, 7th. The company reported ($0.30) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.53) by $0.23. The firm earned $3.58 million during the quarter. View MeiraGTx's Earnings History.

MeiraGTx is scheduled to release their next quarterly earnings announcement on Tuesday, March 24th 2020. View Earnings Estimates for MeiraGTx.

3 analysts have issued 12-month price targets for MeiraGTx's shares. Their forecasts range from $30.00 to $45.00. On average, they expect MeiraGTx's share price to reach $38.33 in the next year. This suggests a possible upside of 110.7% from the stock's current price. View Analyst Price Targets for MeiraGTx.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MeiraGTx in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for MeiraGTx.

Press coverage about MGTX stock has been trending extremely negative on Sunday, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. MeiraGTx earned a news sentiment score of -4.5 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the next several days. View News Stories for MeiraGTx.

MeiraGTx saw a increase in short interest in the month of January. As of January 15th, there was short interest totalling 841,500 shares, an increase of 11.4% from the December 31st total of 755,700 shares. Based on an average daily trading volume, of 156,600 shares, the short-interest ratio is presently 5.4 days. Approximately 3.2% of the company's stock are sold short. View MeiraGTx's Current Options Chain.

Some companies that are related to MeiraGTx include Audentes Therapeutics (BOLD), Denali Therapeutics (DNLI), Fate Therapeutics (FATE), Alector (ALEC), Regenxbio (RGNX), Cortexyme (CRTX), SpringWorks Therapeutics (SWTX), Editas Medicine (EDIT), Coherus Biosciences (CHRS), Orchard Therapeutics (ORTX), DBV TECHNOLOGIE/S (DBVT), NanoString Technologies (NSTG), Mesoblast (MESO), Aerie Pharmaceuticals (AERI) and Krystal Biotech (KRYS).

Based on aggregate information from My MarketBeat watchlists, some companies that other MeiraGTx investors own include AbbVie (ABBV), Kadmon (KDMN), Crispr Therapeutics (CRSP), Fate Therapeutics (FATE), Corbus Pharmaceuticals (CRBP), Exelixis (EXEL), Galmed Pharmaceuticals (GLMD), Intercept Pharmaceuticals (ICPT), InVitae (NVTA) and Agile Therapeutics (AGRX).

(MGTX) raised $75 million in an initial public offering (IPO) on Friday, June 8th 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch, Barclays and Evercore ISI served as the underwriters for the IPO and Chardan was co-manager.

MeiraGTx's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Rhenman & Partners Asset Management AB (0.52%) and Focused Wealth Management Inc (0.01%). Company insiders that own MeiraGTx stock include Life Sciences Maste Perceptive, Nicole Seligman and Richard Giroux. View Institutional Ownership Trends for MeiraGTx.

MGTX stock was bought by a variety of institutional investors in the last quarter, including Rhenman & Partners Asset Management AB and Focused Wealth Management Inc. Company insiders that have bought MeiraGTx stock in the last two years include Life Sciences Maste Perceptive and Nicole Seligman. View Insider Buying and Selling for MeiraGTx.

Shares of MGTX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MGTX stock can currently be purchased for approximately $18.19.

MeiraGTx has a market capitalization of $665.21 million. The company earns $-82,870,000.00 in net income (profit) each year or ($4.39) on an earnings per share basis. MeiraGTx employs 68 workers across the globe.View Additional Information About MeiraGTx.

The official website for MeiraGTx is http://www.meiragtx.com/.

MeiraGTx's mailing address is 450 East 29thStreet 15thFloor, NEW YORK NY, 10016. The company can be reached via phone at 646-860-7985 or via email at [email protected]